The small-cap Russell 2000 hit its first intraday record high on Friday since the U.S.-Iran conflict erupted, joining other major indexes at all-time highs and suggesting the recent equities rally is broadening beyond large companies.
Institutional ownership declined across several Nifty 500 stocks in Q4FY26, including Newgen Software Technologies and Adani Enterprises, signalling portfolio rebalancing and cautious sentiment among FIIs and DIIs as they trimmed exposure to select counters.
Securities and Exchange Board of India approved National Stock Exchange of India investment in a coal exchange to enable transparent trading while revising intermediary norms removing automatic disqualification from complaints but tightening rules upon conviction and mandating timely disclosures
Jio Financial Q4 Results: Jio Financial Services on Friday reported a 14% year-on-year decline in its consolidated net profit for the quarter ended March 31, 2026 at Rs 272 crore compared to Rs 316 crore in the year ago period even as revenue surged 106% to Rs 1,019 crore.
D-Street saw sharp stock-specific action as Bajaj Consumer Care, Kolte-Patil Developers, and Waaree Renewable Technologies surged on strong earnings, while Wipro and Gallantt Ispat declined amid weak results and profit booking.
Several Indian stocks hit new 52 week highs with monthly gains led by Bharat Heavy Electricals and Nippon Life India Asset Management alongside Sona BLW Precision Forgings Laurus Labs NMDC NLC India Steel Authority of India National Aluminium Company Cummins India and Aurobindo Pharma
Trent Ltd on Friday informed the exchanges that its board will meet on April 22 to consider a bonus issue of shares to investors, subject to approval of the shareholders. The company will also declare financial results on the same day.
Central banks like the Federal Reserve control market direction through liquidity. Abundant money fuels asset prices, while tightening liquidity can stall markets. Even strong company earnings may not boost stock values when money is scarce. Investors should monitor central bank actions and liquidity flows for market insights.
Windlas Biotech approved a Rs 47 crore share buyback at Rs 1,000 per share via the tender route, with April 24 set as the record date. The move covers 2.23% equity and excludes promoters. Shares rose 2% following the announcement, reflecting positive investor sentiment toward the capital return plan.
Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.